NOS3 and rheumatoid arthritis: As reported in a recent review [23], RA-associated ED is secondary to decreased NO availability, decreased endothelial NOS expression/activity, uncoupling of endothelial NOS, increased arginase activity, excess of superoxide anion production, impaired EDHF production, increased synthesis of prostanoids and increased angiotensin II production.